ArticleCancers2022

Identification of Src Family Kinases as Potential Therapeutic Targets for Chemotherapy-Resistant Triple Negative Breast Cancer.

Ishwar N Kohale et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.